跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EZECREST COMPOSITE PACK 10 mg+40 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 40 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
EZECREST COMPOSITE PACK 10 mg+40 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 40 mg tablet blister composite pack
Approved
STANDARD
EZECREST COMPOSITE PACK 10 mg+40 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 40 mg tablet blister composite pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
75ffa5a8bdaf330c
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
75ffa5a8bdaf330c
Product Name
EZECREST COMPOSITE PACK 10 mg+40 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 40 mg tablet blister composite pack
Artg Id
375670
Artg Name
EZECREST COMPOSITE PACK 10 mg+40 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 40 mg tablet blister composite pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2023-02-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b730b2bd6e8a584b88816e4c704dd22c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/266c788eef30dcbbea046f015c262491.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
75ffa5a8bdaf330c
Type
Standard
Back to TGA Approvals